Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed)
Key Information
Due Date: July 3, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Cooperative Agreement
Match Required: No
Status: Closed
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The UG3/UH3 research projects funded under this program aim to enable the discovery of new immune pathways and immunoprevention mechanisms. They also encourage the exploration of new vaccine or immunomodulatory targets or agents. Interested applicants must submit a single application for both the UG3 and UH3 phases. The successful completion of the UG3 phase milestones is a prerequisite for moving on to the UH3 phase. Once the UG3 phase is successfully completed and administratively reviewed, the UH3 phase may commence and continue, assuming that all objectives are being met.
Key Dates
Open Date: April 20, 2023
Application Due Date: July 3, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses